PPARδ agonist raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-06-04 and is reviewed periodically as new material appears.
Published human data are sparse and mostly come from early-phase trials. Those studies examined short-term changes in lipids, glucose, and exercise capacity, but they were not large enough to establish efficacy or long-term safety. Some animal experiments reported increased running endurance, yet such findings do not prove a performance benefit in people. Anti-doping laboratories detect GW501516 and its metabolites in urine or blood using liquid chromatography-tandem mass spectrometry. Detection windows depend on dose, sample type, and individual metabolism. The method is sensitive enough to identify trace residues in tested samples.
Laboratory handling focuses on identity, purity, and stability. Reference standards are typically stored cold and dry, protected from light, because solutions can degrade over time. Analytical checks may use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Impurities and related substances can be separated chromatographically and compared with a known standard. Because cardarine is not an approved drug, compendial monographs are absent, and laboratories often rely on in-house methods. Reported purity varies among unregulated products and should not be assumed from a label.
Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.
Cardarine is a common name for GW501516, an investigational compound developed in the 1990s for metabolic conditions. It acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in lipid and energy metabolism. The compound is frequently mislabeled as a selective androgen receptor modulator, or SARM, but its molecular target is different. GW501516 reached early clinical testing before development was discontinued. It has no approved therapeutic use in any country. The name cardarine is not a formal international nonproprietary name.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white solid | Typical form of reference material |
| Solubility | Low in water; soluble in DMSO | Used to prepare stock solutions |
| Typical storage | -20 °C, desiccated, protected from light | Common laboratory practice |
| Analytical method | LC-MS/MS | Detects parent compound and metabolites |
| Common test matrix | Urine or blood | Used in anti-doping analysis |
Anti-doping laboratories detect GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be used in some programs. Detection depends on factors such as dose, timing, metabolism, and the sensitivity of the assay. Published methods describe limits of detection in the low nanogram per milliliter range for related compounds. Exact detection windows are not fixed for all situations and remain an area of ongoing study.
Products sold as cardarine have been found to contain incorrect compounds, variable amounts, or no active ingredient at all. Independent testing is required to verify identity and purity. Common analytical approaches include high-performance liquid chromatography, mass spectrometry, and nuclear magnetic resonance for structural confirmation. These methods can distinguish GW501516 from related PPAR agonists and from unrelated steroids. For regulators and researchers, such verification is central to interpreting both biological results and adverse event reports.
The compound is typically described as a laboratory compound rather than a therapeutic product. Published reports have explored its role in lipid disorders, insulin sensitivity, and exercise metabolism, yet no major drug regulator has approved it for medical use. Commercial samples sold under the cardarine name may vary in purity and identity. Analytical confirmation is therefore necessary when the material is discussed in scientific or regulatory contexts. Its classification as a prohibited substance in sport further shapes how it is studied and reported.
Cardarine is a common name for GW501516, a synthetic compound studied for its effects on lipid and glucose metabolism. It functions as an agonist at peroxisome proliferator-activated receptor delta, or PPARδ, a nuclear receptor that influences gene expression. The molecule is not a steroid, nor is it a selective androgen receptor modulator. It is also known in research and sports literature as GW-501516 and endurobol. Early laboratory work examined its metabolic activity in cell cultures and animal models.
Detection of GW501516 in biological samples generally relies on liquid chromatography coupled with tandem mass spectrometry. Urine is a common matrix in anti-doping analysis, while blood or plasma may be used in research settings. Sample preparation can involve enzymatic hydrolysis, protein precipitation, or solid-phase extraction before instrumental analysis. Because the compound undergoes metabolism, assays may target the parent molecule, one or more metabolites, or both. Detection windows are not fixed; they depend on factors such as dose, route, individual metabolism, and assay sensitivity. Reference standards are required for accurate identification and quantification.
Handling and quality assessment of cardarine reference material follow general laboratory practices for poorly characterized compounds. It typically appears as a white to off-white powder and is sparingly soluble in water but soluble in organic solvents such as dimethyl sulfoxide and ethanol. Storage recommendations usually specify a cool, dry, dark place, with long-term storage at low temperature and desiccation. Purity may be checked by high-performance liquid chromatography with ultraviolet detection, while identity is confirmed by mass spectrometry and nuclear magnetic resonance. No pharmacopeial monograph exists, so reported purity and stability depend on the supplier’s methods.
==== Magnetic tape ==== Magnetic tape was for a long time the most commonly used medium for bulk data storage, backup, archiving, and interchange. It was previously a less expensive option, but this is no longer the case for smaller amounts of data. Tape is a sequential access medium, so the rate of continuously writing or reading data can be very fast. While tape media itself has a low cost per space, tape drives are typically dozens of times as expensive as hard disk drives and optical drives. Tape media are generally rotated on a schedule so at least one set is off-site in case something should happen to the building where the primary copy of the data lives. Many tape formats have been proprietary or specific to certain markets like mainframes or a particular brand of personal computer. By 2014 LTO had become the primary tape technology. The other remaining viable "super" format is the IBM 3592 (also referred to as the TS11xx series). The Oracle StorageTek T10000 was discontinued in 2016.
== Preliminary research == Although ergothioneine is under preliminary research, its physiological role in vivo has not been determined. Mammals use the OCTN1 transporter to move ergothioneine into cells. Knockout of this gene in mouse and zebrafish models produces no substantial overt defect, though stress does amplify the differences.
The knockout stage used a single-elimination format, starting with the newly introduced round of 32 on June 28 and culminating with the final on July 19, with a match for third place the day before. If the score was even after regulation time in a match, 30 minutes of extra time were added. If still tied after this, a penalty shootout determined the winner.
1942, 'Obituary: Prof. Rudolf Schoenheimer' Nature. 1942; 149, pp. 15–16 Schoenheimer, R 1931, 'New Contributions in Sterol Metabolism', Science, New Series, vol. 74, no. 1928, pp. 579–584 Schoenheimer, R 1942, 'The Dynamic State Of Body Constituents' Cancer Research, vol. 2, no. 11, p. 810. Simoni, R.D, Hill, R.L, & Vaughan, M 2002, 'The Use of Isotope Tracers to Study Intermediary Metabolism: Rudolph Schoenheimer', The Journal of Biological Chemistry, vol. 277, No. 43 'Schoenheimer, Rudolf'Complete Dictionary of Scientific Biography, Encyclopedia.com. 23 Apr. 2020 https://www.encyclopedia.com
==== United States ==== The US Food and Drug Administration (FDA) considers safe beverages containing less than 0.02% caffeine; but caffeine powder, which is sold as a dietary supplement, is unregulated. It is a regulatory requirement that the label of most prepackaged foods must declare a list of ingredients, including food additives such as caffeine, in descending order of proportion. However, there is no regulatory provision for mandatory quantitative labeling of caffeine, (e.g., milligrams caffeine per stated serving size). There are a number of food ingredients that naturally contain caffeine. These ingredients must appear in food ingredient lists. However, as is the case for "food additive caffeine", there is no requirement to identify the quantitative amount of caffeine in composite foods containing ingredients that are natural sources of caffeine. While coffee or chocolate are broadly recognized as caffeine sources, some ingredients (e.g., guarana, yerba maté) are likely less recognized as caffeine sources. For these natural sources of caffeine, there is no regulatory provision requiring that a food label identify the presence of caffeine nor state the amount of caffeine present in the food. The FDA guidance was updated in 2018.
Sources: en.wikipedia.org
=== Allegations of illegal marketing === In 2004, separate civil suits alleging illegal marketing of citalopram and escitalopram for use by children and teenagers by Forest were initiated by two whistleblowers: a physician named Joseph Piacentile and a Forest salesman named Christopher Gobble. In February 2009, the suits were joined. Eleven states and the District of Columbia filed notices of intent to intervene as plaintiffs in the action. The suits alleged that Forest illegally engaged in off-label promotion of Lexapro for use in children; hid the results of a study showing lack of effectiveness in children; paid kickbacks to physicians to induce them to prescribe Lexapro to children; and conducted so-called "seeding studies" that were, in reality, marketing efforts to promote the drug's use by doctors. Forest denied the allegations but ultimately agreed to settle with the plaintiffs for over $313 million.
=== Education and early law career === Duterte went to Laboon Elementary School in Maasin for a year. He spent his remaining elementary days at Santa Ana Elementary School in Davao City, where he completed his primary education in 1956. He finished his secondary education in the High School Department of Holy Cross College of Digos (now Cor Jesu College) in Digos, Davao province, after being expelled twice from previous schools, including one in the Ateneo de Davao University (AdDU) High School due to misconduct. He graduated in 1968 with a Bachelor of Arts degree in political science at the Lyceum of the Philippines in Manila. Duterte obtained a law degree from San Beda College of Law in 1972, passing the bar exam in the same year. He worked as a professor in the national police academy, and was a member of an organization called Nationalist Alliance for Justice, Freedom and Democracy. He later served as the OIC vice mayor of Davao City, assisting evacuees from Davao City remote areas and working for the release of soldiers captured by the New Peoples Army (NPA). Eventually, he became a special counsel at the City Prosecution Office in Davao City from 1977 to 1979, fourth assistant city prosecutor from 1979 to 1981, third assistant city prosecutor from 1981 to 1983, and second assistant city prosecutor from 1983 to 1986.
In 2016, DeepMind's WaveNet demonstrated that deep neural networks can generate raw audio waveforms. This enabled more realistic speech synthesis compared to earlier approaches. Subsequent systems such as Tacotron 2 demonstrated end-to-end neural text-to-speech generation.
The upper gastrointestinal tract consists of the mouth, pharynx, esophagus, stomach, and duodenum. The exact demarcation between the upper and lower tracts is the suspensory muscle of the duodenum. This differentiates the embryonic borders between the foregut and midgut, and is also the division commonly used by clinicians to describe gastrointestinal bleeding as being of either "upper" or "lower" origin. Upon dissection, the duodenum may appear to be a unified organ, but it is divided into four segments based on function, location, and internal anatomy. The four segments of the duodenum are as follows (starting at the stomach, and moving toward the jejunum): bulb, descending, horizontal, and ascending. The suspensory muscle of the duodenum suspends the superior border of the ascending duodenum from the diaphragm, and serves as an important anatomical landmark showing the formal division between the duodenum and the jejunum, the first and second parts of the small intestine, respectively. This is a thin muscle which is derived from the embryonic mesoderm.
Sources: en.wikipedia.org
In an edition of the Ars Quatuor Coronatorum, the quarterly historical journal of the Quatuor Coronati Lodge, Masonic historian Robert Freke Gould verified the existence of a membership certificate issued by this Military Lodge. The document, 8.75 inches long and 8.5 inches wide, was a parchment sealed with a red wax seal, and tied with a yellow and blue ribbon. The membership certificate stated:
== Scope of accreditation == NABL's scope for accreditation extends to:- Testing Laboratories: Biological, Chemical, Diagnostic Radiology QA testing, Electrical, Electronics, Fluid-Flow, Forensic, Mechanical, Non-Destructive testing, Photometry, Radiological and Software & IT system testing. Calibration Laboratories: Electro-Technical, Mechanical, Fluid Flow, Thermal & Optical, Radiological, Thermal. Medical Laboratories: Clinical Biochemistry, Clinical Pathology, Haematology & Immunohaematology, Microbiology and Infectious Disease Serology, Molecular Diagnostics, Histocompatibility & Immunogenetics, Medical Imaging, Histopathology, Cytopathology, Flow cytometry, Cytogenetics.
This advance enables the enantioselective construction of three-dimensional, sp³-rich molecules used in drug discovery and total synthesis. Sulfonyl hydrazides are commercially available as reagent feedstock.
Diazepam is a long-acting "classical" benzodiazepine. Other classical benzodiazepines include chlordiazepoxide, clonazepam, lorazepam, oxazepam, nitrazepam, temazepam, flurazepam, bromazepam, and clorazepate. Diazepam has anticonvulsant properties. Benzodiazepines act via micromolar benzodiazepine binding sites as calcium channel blockers and significantly inhibit depolarization-sensitive calcium uptake in rat nerve cell preparations. Diazepam inhibits acetylcholine release in mouse hippocampal synaptosomes. This has been found by measuring sodium-dependent high-affinity choline uptake in mouse brain cells in vitro, after pretreatment of the mice with diazepam in vivo. This may play a role in explaining diazepam's anticonvulsant properties. Diazepam binds with high affinity to glial cells in animal cell cultures. Diazepam at high doses has been found to decrease histamine turnover in mouse brain via diazepam's action at the benzodiazepine-GABA receptor complex. Diazepam also decreases prolactin release in rats.
=== Exosomes to deliver treatments across the blood–brain barrier === A group from the University of Oxford led by Prof. Matthew Wood claims that exosomes can cross the blood–brain barrier and deliver siRNAs, antisense oligonucleotides, chemotherapeutic agents and proteins specifically to neurons after inject them systemically (in blood). Because these exosomes are able to cross the blood–brain barrier, this protocol could solve the issue of poor delivery of medications to the central nervous system and cure Alzheimer's, Parkinson's Disease and brain cancer, among other diseases. The laboratory has been recently awarded a major new €30 million project leading experts from 14 academic institutions, two biotechnology companies and seven pharmaceutical companies to translate the concept to the clinic.
Sources: en.wikipedia.org
Anti-doping and clinical laboratories commonly use liquid chromatography-tandem mass spectrometry. The method can identify GW501516 and its metabolites in urine or blood. Detection depends on sample timing and the amount present.
PPARδ is a nuclear receptor that regulates genes linked to fatty acid oxidation and energy metabolism. Activation can alter lipid handling and energy use in experimental models. The full range of effects in humans is still under study.
The solid compound is generally stable when kept cold, dry, and protected from light. Solutions may degrade faster, so laboratory protocols often specify fresh preparation or cold storage. Stability can depend on solvent, concentration, and container.
No. Cardarine is GW501516, a PPARδ agonist, while SARMs act on androgen receptors. The two classes are often grouped in informal discussions despite different mechanisms.